Compare PRME & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRME | BVS |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 601.1M | 508.4M |
| IPO Year | 2022 | 2021 |
| Metric | PRME | BVS |
|---|---|---|
| Price | $4.01 | $7.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $9.31 | ★ $13.33 |
| AVG Volume (30 Days) | ★ 3.8M | 289.0K |
| Earning Date | 11-07-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | $5,977,000.00 | ★ $563,829,000.00 |
| Revenue This Year | $111.80 | N/A |
| Revenue Next Year | N/A | $7.11 |
| P/E Ratio | ★ N/A | $49.19 |
| Revenue Growth | ★ 647.13 | 1.58 |
| 52 Week Low | $1.11 | $5.81 |
| 52 Week High | $6.94 | $11.75 |
| Indicator | PRME | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 49.51 | 53.55 |
| Support Level | $3.95 | $7.02 |
| Resistance Level | $4.42 | $7.70 |
| Average True Range (ATR) | 0.31 | 0.31 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 65.09 | 59.87 |
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.